EUVIMEDEUVIMED entdecken
Multizentrische StudieKlinische StudieOpen Access

First Prospective, Single-Arm, Multicenter Study to Evaluate the Safety and Efficacy of the Overall Thrombectomy System for Stroke: iNedit, iNdeep, and iNtercept in Patients with Acute Ischemic Stroke (SEMTiC-01 Study)

Oscar Chirife, Guillem Dolz, Fernando Delgado, Alejandro Tomasello, Pedro Vega, Manuel Moreu iD, Carlos Castaño, Fernando Aparici, Carlos Domínguez, Markus Holtmannspötter, Olivier François, Eva González und 13 weitere

American Journal of Neuroradiology · 2026

DOI: 10.3174/ajnr.a9247 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift American Journal of Neuroradiology, 2026. Verfasst von Oscar Chirife und 24 weiteren Autor:innen. Beteiligte Einrichtung: From the IDIBELL (Institut d'Investigació Biomèdica de Bellvitge) (O.C.), Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, Spa…. Hauptthemen laut MEDLINE: Ischemic Stroke, Thrombectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: S.L.U., Sant Vicenç dels Horts, Spain.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: Mechanical thrombectomy (MT) is the standard of care for acute ischemic stroke (AIS) due to large vessel occlusion (LVO), but the optimal combination of devices remains under investigation. The Safety and Efficacy of the Overall Thrombectomy System for Stroke (SEMTiC-01) trial evaluates the safety and efficacy of a novel, fully integrated neurothrombectomy system composed of the iNedit balloon distal access catheter, the iNdeep microcatheter, and the iNtercept stent retriever. MATERIALS AND METHODS: SEMTiC-01 is a prospective, multicenter, single-arm, open-label trial conducted across 18 centers in Spain, Germany, and Belgium. A total of 175 patients with LVO stroke were enrolled and treated within 24 hours of symptom onset. The primary efficacy end point was the rate of successful reperfusion (expanded Thrombolysis in Cerebral Infarction [eTICI] score ≥2b) in ≤3 passes. The primary safety end points included serious adverse events within 24 hours and 90-day mortality. Secondary end points included good functional outcome (mRS 0-2 at 90 days), early neurologic improvement, and device navigability. RESULTS: Successful reperfusion was achieved in 75.4% of the intention-to-treat (ITT) and 83.6% of the per-protocol (PP) population. Good functional outcomes were observed in 55.8% (ITT) and 56.9% (PP), and rapid neurologic improvement in 64.6% of patients. First-pass reperfusion (eTICI ≥2b) was obtained in 46.9% (ITT) and 51.4% (PP). Symptomatic intracranial hemorrhage occurred in 1.7% (ITT), and mortality at 90 days was 13.7%. Device navigability was rated good in more than 75% of cases for both iNedit, iNtercept, and iNdeep. Balloon inflation during thrombectomy improved outcomes in M1 occlusions. CONCLUSIONS: The triad system (iNedit, iNdeep, and iNtercept) demonstrates noninferiority compared with published literature, with favorable safety and efficacy profiles. Its favorable navigability suggests it is a promising option for MT in AIS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ischemic StrokeThrombectomyHumansFemaleMaleTreatment OutcomeProspective StudiesAgedMiddle AgedAged, 80 and overEquipment DesignEquipment Failure Analysis

Autor:innen und Institutionen

  • From the IDIBELL (Institut d'Investigació Biomèdica de Bellvitge) (O.C.), Hospital Universitari de Bellvitge, University of Barcelona, Barcelona, Spain.
  • Neurointerventional Department CDI (G.D., L.S.R., J.M.), Hospital Clinic de Barcelona, Barcelona, Spain.
  • Interventional Neuroradiology, Department of Radiology (F.D.), Reina Sofía University Hospital, Cordoba, Spain.
  • Interventional Neuroradiology Section (A.T., L.L.G.), Vall D'Hebron University Hospital, Barcelona, Spain.
  • Department of Radiology (P.V.), Hospital Universitario Central de Asturias, Oviedo, Asturias, Spain.
  • Interventional Neuroradiology Section (M. Moreu), Hospital Clinico San Carlos, Madrid, Spain.

ORCID-Profile: Manuel Moreu, Stephan Meckel

Förderung

  • S.L.U., Sant Vicenç dels Horts, Spain

Zitieren

APA

Chirife, O., Dolz, G., Delgado, F., Tomasello, A., Vega, P., Moreu, M., Castaño, C., Aparici, F., Domínguez, C., Holtmannspötter, M., François, O., González, E., Aguilar, Y., Fernández, L., Castro Reyes, E., Meckel, S., Gramegna, L. L., Quintana Luque, M., Pich, S., …, & Macho, J. (2026). First Prospective, Single-Arm, Multicenter Study to Evaluate the Safety and Efficacy of the Overall Thrombectomy System for Stroke: iNedit, iNdeep, and iNtercept in Patients with Acute Ischemic Stroke (SEMTiC-01 Study). American Journal of Neuroradiology. https://doi.org/10.3174/ajnr.a9247

Vancouver

Chirife O, Dolz G, Delgado F, Tomasello A, Vega P, Moreu M, et al. First Prospective, Single-Arm, Multicenter Study to Evaluate the Safety and Efficacy of the Overall Thrombectomy System for Stroke: iNedit, iNdeep, and iNtercept in Patients with Acute Ischemic Stroke (SEMTiC-01 Study). American Journal of Neuroradiology. 2026. doi:10.3174/ajnr.a9247

BibTeX
@article{Chirife2026,
  author = {Chirife, Oscar and Dolz, Guillem and Delgado, Fernando and Tomasello, Alejandro and Vega, Pedro and Moreu, Manuel and Castaño, Carlos and Aparici, Fernando and Domínguez, Carlos and Holtmannspötter, Markus and François, Olivier and González, Eva and Aguilar, Yeray and Fernández, Luis and Castro Reyes, Enrique and Meckel, Stephan and Gramegna, Laura Ludovica and Quintana Luque, Manuel and Pich, Sara and Domingo-Rodriguez, Laura and Duran, Marta and Molina, María and Duocastella, Lluís and San Román, Luis and Macho, Juan},
  title = {First Prospective, Single-Arm, Multicenter Study to Evaluate the Safety and Efficacy of the Overall Thrombectomy System for Stroke: iNedit, iNdeep, and iNtercept in Patients with Acute Ischemic Stroke (SEMTiC-01 Study)},
  journal = {American Journal of Neuroradiology},
  year = {2026},
  doi = {10.3174/ajnr.a9247}
}
Kostenlos starten →